PharmaCielo Provides Update - PharmaCielo is actively working with, and has recently shipped product to, established companies in Argentina, Brazil, Colombia and Paraguay.
- The Company's sales and technical teams are providing support to these customers as they conduct testing and advance product registrations using PharmaCielo APIsi, to market.
TORONTO and RIONEGRO, Colombia, Feb. 4, 2022 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. ("Holdings"), today provided investors with an update on its Latin American sales progress and its non-brokered private placement of debenture units.